Elizabeth G Faust, MD - Medicare Psychiatry in Bremerton, WA

Elizabeth G Faust, MD is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Bremerton, Washington. She went to Texas A & M University System, Hsc, College Of Medicine and graduated in 1999 and has 25 years of diverse experience with area of expertise as Psychiatry. She is a member of the group practice Mccd Fl Psychiatry Services Pa, Mccd Fl Psychiatry Services Pa, Mccd Fl Psychiatry Services Pa and her current practice location is 2520 Cherry Ave, Bremerton, Washington. You can reach out to her office (for appointments etc.) via phone at (360) 744-1851.

Elizabeth G Faust is licensed to practice in Washington (license number MD60402151) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1629027495.

Contact Information

Elizabeth G Faust, MD
2520 Cherry Ave,
Bremerton, WA 98310-4229
(360) 744-1851
(253) 985-6879



Physician's Profile

Full NameElizabeth G Faust
GenderFemale
SpecialityPsychiatry
Experience25 Years
Location2520 Cherry Ave, Bremerton, Washington
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Elizabeth G Faust attended and graduated from Texas A & M University System, Hsc, College Of Medicine in 1999
  NPI Data:
  • NPI Number: 1629027495
  • Provider Enumeration Date: 05/09/2006
  • Last Update Date: 12/03/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 9537395488
  • Enrollment ID: I20131122001540

Medical Identifiers

Medical identifiers for Elizabeth G Faust such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1629027495NPI-NPPES
2032135MedicaidWA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry 50255-20 (Wisconsin)Secondary
390200000XStudent In An Organized Health Care Education/training Program 50255 (Wisconsin)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry 1020-TEP (Wisconsin)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry MD60402151 (Washington)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Mccd Fl Psychiatry Services Pa4880064070206
Mccd Fl Psychiatry Services Pa4880064070206
Mccd Fl Psychiatry Services Pa4880064070206

News Archive

Research confirms that probiotic bacteria promotes health and boosts immune system

Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.

UofL to receive Grand Challenges tuberculosis biomarkers grant

The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."

Celera reports net revenue of $34.9 million for fourth quarter of 2010

Celera Corporation today reported net revenues of $34.9 million for the fourth quarter of 2010 that ended December 25, 2010, compared to $39.2 million for the prior year quarter.

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

A team of researchers from the US and Belgium applied a structure-based approach with early monitoring of cathepsin L inhibition along with SARS-CoV-2 3CLpro inhibition. They identified a potent and selective SARS-CoV-2 3CLpro inhibitor, ALG-097111, which has proven activity against SARS-CoV-2 in SARS-CoV-2 hamster models in vivo. This study is published in the journal, Biochemical and Biophysical Research Communications.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Elizabeth G Faust allows following entities to bill medicare on her behalf.
Entity NameFranciscan Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093165334
PECOS PAC ID: 0547173866
Enrollment ID: O20031111000789

News Archive

Research confirms that probiotic bacteria promotes health and boosts immune system

Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.

UofL to receive Grand Challenges tuberculosis biomarkers grant

The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."

Celera reports net revenue of $34.9 million for fourth quarter of 2010

Celera Corporation today reported net revenues of $34.9 million for the fourth quarter of 2010 that ended December 25, 2010, compared to $39.2 million for the prior year quarter.

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

A team of researchers from the US and Belgium applied a structure-based approach with early monitoring of cathepsin L inhibition along with SARS-CoV-2 3CLpro inhibition. They identified a potent and selective SARS-CoV-2 3CLpro inhibitor, ALG-097111, which has proven activity against SARS-CoV-2 in SARS-CoV-2 hamster models in vivo. This study is published in the journal, Biochemical and Biophysical Research Communications.

Read more Medical News

› Verified 4 days ago

Entity NameKaiser Foundation Health Plan Of Washington
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1396810701
PECOS PAC ID: 9032022579
Enrollment ID: O20031112000454

News Archive

Research confirms that probiotic bacteria promotes health and boosts immune system

Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.

UofL to receive Grand Challenges tuberculosis biomarkers grant

The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."

Celera reports net revenue of $34.9 million for fourth quarter of 2010

Celera Corporation today reported net revenues of $34.9 million for the fourth quarter of 2010 that ended December 25, 2010, compared to $39.2 million for the prior year quarter.

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

A team of researchers from the US and Belgium applied a structure-based approach with early monitoring of cathepsin L inhibition along with SARS-CoV-2 3CLpro inhibition. They identified a potent and selective SARS-CoV-2 3CLpro inhibitor, ALG-097111, which has proven activity against SARS-CoV-2 in SARS-CoV-2 hamster models in vivo. This study is published in the journal, Biochemical and Biophysical Research Communications.

Read more Medical News

› Verified 4 days ago

Entity NameMccd Fl Psychiatry Services Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659003457
PECOS PAC ID: 4880064070
Enrollment ID: O20230519000385

News Archive

Research confirms that probiotic bacteria promotes health and boosts immune system

Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.

UofL to receive Grand Challenges tuberculosis biomarkers grant

The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."

Celera reports net revenue of $34.9 million for fourth quarter of 2010

Celera Corporation today reported net revenues of $34.9 million for the fourth quarter of 2010 that ended December 25, 2010, compared to $39.2 million for the prior year quarter.

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

A team of researchers from the US and Belgium applied a structure-based approach with early monitoring of cathepsin L inhibition along with SARS-CoV-2 3CLpro inhibition. They identified a potent and selective SARS-CoV-2 3CLpro inhibitor, ALG-097111, which has proven activity against SARS-CoV-2 in SARS-CoV-2 hamster models in vivo. This study is published in the journal, Biochemical and Biophysical Research Communications.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Elizabeth G Faust is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Elizabeth G Faust, MD
2520 Cherry Ave,
Bremerton, WA 98310-4229

Ph: (360) 744-1851
Elizabeth G Faust, MD
2520 Cherry Ave,
Bremerton, WA 98310-4229

Ph: (360) 744-1851

News Archive

Research confirms that probiotic bacteria promotes health and boosts immune system

Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.

UofL to receive Grand Challenges tuberculosis biomarkers grant

The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."

Celera reports net revenue of $34.9 million for fourth quarter of 2010

Celera Corporation today reported net revenues of $34.9 million for the fourth quarter of 2010 that ended December 25, 2010, compared to $39.2 million for the prior year quarter.

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

A team of researchers from the US and Belgium applied a structure-based approach with early monitoring of cathepsin L inhibition along with SARS-CoV-2 3CLpro inhibition. They identified a potent and selective SARS-CoV-2 3CLpro inhibitor, ALG-097111, which has proven activity against SARS-CoV-2 in SARS-CoV-2 hamster models in vivo. This study is published in the journal, Biochemical and Biophysical Research Communications.

Read more News

› Verified 4 days ago


Psychiatry & Neurology Doctors in Bremerton, WA

Dr. Meghann Elise Sprague, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 555 Pacific Ave Ste 202, Bremerton, WA 98337
Phone: 360-782-1700    
Dr. Linda Semlitz Gilbert, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 5455 Almira Dr Ne, Bremerton, WA 98311
Phone: 360-479-4994    
Karl G Baer, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 5455 Almira Dr Se, Bremerton, WA 98311
Phone: 360-373-6819    
Antonio Gutierrez, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 5455 Almira Dr Se, Bremerton, WA 98311
Phone: 360-373-5031    
Dr. Josh Lee Duckworth, M.D.
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 1 Boone Rd, Bremerton, WA 98312
Phone: 360-475-4940    
Dr. Saeed Aflatooni, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 2528 Wheaton Way Ste 106, Bremerton, WA 98310
Phone: 360-782-1933    
Robert Charles Reinach, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 5455 Almira Dr Se, Bremerton, WA 98311
Phone: 360-373-5031    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.